【Report vol.1】Greetings from the Representative Director of the 5th Annual Meeting

Report on the 5th Annual Meeting <vol.1>

“Future Clinical Research in Intestinal Flora Transplantation Clinical Research Group: Cancer and Renal Diseases”

Dr. Zen Tanaka, President, Tanaka Clinic, Jinzenkai Medical Corporation

Dr. Zen Tanaka, Representative Director of the board of directors, gave a speech at the beginning of the meeting.
Dr. Zen Tanaka is the President of Tanaka Clinic of Jinseikai Medical Corporation, where he promotes integrative medicine that makes full use of molecular nutrition, immunology, and the dental and oral environment, with a focus on advanced cancer treatment, and practices medicine with the aim of contributing to the development of preventive medicine.

HE ALSO DISCUSSED THE POSSIBILITY THAT FMT MAY INHIBIT THE ONSET AND PROGRESSION OF CANCER BASED ON THE IMPORTANT RELATIONSHIP BETWEEN INTESTINAL FLORA AND IMMUNITY, AND THAT FMT MAY INHIBIT THE DECLINE IN RENAL FUNCTION IN PATIENTS WITH CONSERVATIVE RENAL FAILURE PRIOR TO THE INTRODUCTION OF DIALYSIS, FOR WHOM THERE IS NO ACTIVE TREATMENT METHOD. PLEASE CLICK HERE TO WATCH THE VIDEO.

Dr. Yoshinori Tanaka’s paper was published in “Nutrients”.

An article by Dr. Zen Tanaka (President , Tanaka Clinic, Jinzenkai Medical Corporation ), President of our study group, has been published in “Nutrients”.

Optimizing nutrients, digestive and absorptive capacity, and immunity is important to reduce the risk of cancer, but to do so, it is more important to first optimize the bacteria in the gut, he said.

In the paper, the usefulness of gut flora transplantation (NanoGAS®-FMT) using NanoGAS®︎ water, which is employed in our study group, as one of the methods to optimize gut bacteria, is also introduced.

It is Open Access, so anyone can read it. Please take a moment to read it.